Nathan Rich Stock Analyst Profile - Goldman Sachs Research Coverage - Stocknear

Nathan Rich

Stock Analyst at Goldman Sachs

(3.7)
# 2396
Out of 5,477 analysts
96
Total ratings
Success rate
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
OSCR Oscar Health
Maintains: Neutral
16 21
19.44 8.02% 6 May 9, 2024
ZTS Zoetis
Maintains: Buy
223 196
150.57 30.17% 8 May 6, 2024
XRAY Dentsply Sirona
Maintains: Neutral
34 30
13.94 115.21% 8 May 6, 2024
AMRX Amneal Pharmaceutica...
Maintains: Strong Buy
7 8
10.09 -20.71% 7 May 6, 2024
NVST Envista Holdings
Maintains: Sell
20 18
21.61 -19.02% 4 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
450 385
278.63 38.18% 7 Apr 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
13 14
18.78 -25.45% 9 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 11
19.89 -44.7% 4 Feb 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
197 225
135.91 65.55% 2 Feb 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
500 650
645.16 0.75% 3 Jan 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
35 30
31.33 -4.25% 4 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
350 300
n/a n/a 8 Nov 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
100 88
74.67 17.85% 6 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 12
16.35 -26.61% 6 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
93 85
69.55 22.21% 1 Jul 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
18 16
20.99 -23.77% 1 May 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 11
10.17 8.16% 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
280 240
16.35 1367.89% 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
335
188.35 77.86% 1 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
535
353.64 51.28% 4 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
10
n/a n/a 1 Dec 18, 2019